Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
$7.81
$7.81
$4.06
$9.16
N/AN/AN/AN/A
Flexion Therapeutics, Inc. stock logo
FLXN
Flexion Therapeutics
$9.12
$9.20
$4.30
$13.66
$458.93M1.531.18 million shsN/A
Kadmon Holdings Inc stock logo
KDMN
Kadmon
$9.50
$9.50
$3.19
$9.50
$1.70BN/A5.11 million shs1,052 shs
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
$1.12
-1.8%
$1.29
$0.70
$2.44
$13.19M0.59160,893 shs22,462 shs
Vectura Group plc stock logo
VEGPF
Vectura Group
$1.77
$1.77
$1.64
$2.74
$1.07B0.372,185 shsN/A
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
0.00%0.00%0.00%0.00%0.00%
Flexion Therapeutics, Inc. stock logo
FLXN
Flexion Therapeutics
0.00%0.00%0.00%0.00%0.00%
Kadmon Holdings Inc stock logo
KDMN
Kadmon
0.00%0.00%0.00%0.00%0.00%
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
+0.88%-3.88%+3.64%+17.53%-31.33%
Vectura Group plc stock logo
VEGPF
Vectura Group
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
N/AN/AN/AN/AN/AN/AN/AN/A
Flexion Therapeutics, Inc. stock logo
FLXN
Flexion Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
Kadmon Holdings Inc stock logo
KDMN
Kadmon
N/AN/AN/AN/AN/AN/AN/AN/A
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
1.5132 of 5 stars
0.05.00.00.02.21.70.6
Vectura Group plc stock logo
VEGPF
Vectura Group
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
0.00
N/AN/AN/A
Flexion Therapeutics, Inc. stock logo
FLXN
Flexion Therapeutics
0.00
N/AN/AN/A
Kadmon Holdings Inc stock logo
KDMN
Kadmon
0.00
N/AN/AN/A
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
0.00
N/AN/AN/A
Vectura Group plc stock logo
VEGPF
Vectura Group
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
N/AN/AN/AN/AN/AN/A
Flexion Therapeutics, Inc. stock logo
FLXN
Flexion Therapeutics
$85.55M5.36N/AN/A($0.34) per share-26.82
Kadmon Holdings Inc stock logo
KDMN
Kadmon
N/AN/AN/AN/AN/AN/A
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
$1.76M7.36N/AN/A$2.37 per share0.47
Vectura Group plc stock logo
VEGPF
Vectura Group
$244.76M4.37$0.28 per share6.33$1.16 per share1.53
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
N/AN/A0.00N/AN/AN/AN/AN/A
Flexion Therapeutics, Inc. stock logo
FLXN
Flexion Therapeutics
-$113.71M-$2.01N/AN/AN/A-100.32%N/A-44.26%N/A
Kadmon Holdings Inc stock logo
KDMN
Kadmon
N/AN/A0.00N/AN/AN/AN/AN/A
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
-$2.18MN/A0.00N/A-114.07%-7.86%-5.46%8/11/2025 (Estimated)
Vectura Group plc stock logo
VEGPF
Vectura Group
$157.16M$0.266.8117.70N/AN/AN/AN/AN/A

Latest TXMD, VEGPF, EMIS, FLXN, and KDMN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/13/2025Q1 2025
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
N/A-$0.06N/A-$0.06N/A$0.39 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
N/AN/AN/AN/AN/A
Flexion Therapeutics, Inc. stock logo
FLXN
Flexion Therapeutics
N/AN/AN/AN/AN/A
Kadmon Holdings Inc stock logo
KDMN
Kadmon
N/AN/AN/AN/AN/A
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
N/AN/AN/AN/AN/A
Vectura Group plc stock logo
VEGPF
Vectura Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
N/AN/AN/A
Flexion Therapeutics, Inc. stock logo
FLXN
Flexion Therapeutics
N/A
4.38
4.05
Kadmon Holdings Inc stock logo
KDMN
Kadmon
N/AN/AN/A
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
N/A
2.64
2.64
Vectura Group plc stock logo
VEGPF
Vectura Group
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
N/A
Flexion Therapeutics, Inc. stock logo
FLXN
Flexion Therapeutics
90.01%
Kadmon Holdings Inc stock logo
KDMN
Kadmon
N/A
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
30.74%
Vectura Group plc stock logo
VEGPF
Vectura Group
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Emisphere Technologies Inc. stock logo
EMIS
Emisphere Technologies
6N/AN/ANot Optionable
Flexion Therapeutics, Inc. stock logo
FLXN
Flexion Therapeutics
25750.32 million45.73 millionOptionable
Kadmon Holdings Inc stock logo
KDMN
Kadmon
N/A178.52 millionN/AOptionable
TherapeuticsMD, Inc. stock logo
TXMD
TherapeuticsMD
42011.57 million11.31 millionOptionable
Vectura Group plc stock logo
VEGPF
Vectura Group
502604.26 millionN/ANot Optionable

Recent News About These Companies

Vectura and Hikma to develop US asthma generic
European Stocks See Mixed Session as U.K.'s FTSE Leads
VECTURA GROUP LS -,000271 (V4TA.BE)
Vectura Group PLC (V4TA.BE)
Results for 'Vectura-Fertin Pharma'
Vectura Group (OTC:VEGPF), Short Interest Report
Carlyle stays in race for Vectura
Form 8.3 - Form-8.3 - VECTURA GROUP PLC - 20210826

Media Sentiment Over Time

Emisphere Technologies stock logo

Emisphere Technologies OTCMKTS:EMIS

$7.81 0.00 (0.00%)
As of 12/9/2020

Emisphere Technologies, Inc. operates as a commercial stage pharmaceutical and drug delivery company in the United States. The company offers oral Eligen B12 Rx, an oral formulation prescription medical food for use by B12 deficient individuals. It is also developing GLP-1, which is in Phase III clinical trial for the treatment of type 2 diabetes and related conditions. The company's preclinical programs focus on the development of oral formulations for the treatment of diabetes; and products in the areas of cardiovascular, appetite suppression, and pain, as well as in the development and expansion of nutritional supplement products. It has license agreements with Novo Nordisk A/S to develop and commercialize oral formulations of GLP-1 receptor agonists in combination with Emisphere carriers, as well as to develop and commercialize oral formulations of Novo Nordisk's insulin using the company's Eligen Technology. The company was formerly known as Clinical Technologies Associates, Inc. and changed its name to Emisphere Technologies, Inc. in 1991. Emisphere Technologies, Inc. was founded in 1986 and is based in Roseland, New Jersey.

Flexion Therapeutics stock logo

Flexion Therapeutics NASDAQ:FLXN

Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA.

Kadmon stock logo

Kadmon NYSE:KDMN

Kadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. Its clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.

TherapeuticsMD stock logo

TherapeuticsMD NASDAQ:TXMD

$1.12 -0.02 (-1.75%)
Closing price 03:37 PM Eastern
Extended Trading
$1.14 +0.02 (+1.79%)
As of 04:21 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Vectura Group stock logo

Vectura Group OTCMKTS:VEGPF

$1.77 0.00 (0.00%)
As of 11/1/2021

Vectura Group Plc engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom.